Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geeta Rao

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|December 25, 2025
Cystathionine Beta-Synthase Promotes Anoikis Resistance and Transcoelomic Metastasis in Ovarian Cancer via the SP1-ITGB1 axisPallab Shaw, Arpan Dey Bhowmik, Akrit Pran Jaswal, et al.
Lancet (London, England)|June 4, 2019
Why now for a Series on gender equality, norms, and health?Gary L Darmstadt, Lori Heise, Geeta Rao Gupta, et al.
EMBO Reports|August 28, 2020
MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancerGeeta Rao, Shailendra Kumar Dhar Dwivedi, Yushan Zhang, et al.
Materials Today (Kidlington, England)|October 3, 2022
Disabling partners in crime: Gold nanoparticles disrupt multicellular communications within the tumor microenvironment to inhibit ovarian tumor aggressivenessYushan Zhang, Chandra Kumar Elechalawar, Wen Yang, et al.
ACS Nano|May 2, 2023
Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS ActivationChandra Kumar Elechalawar, Geeta Rao, Suresh Kumar Gulla, et al.
ACS Nano|March 11, 2024
Correction to "Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation"Chandra Kumar Elechalawar, Geeta Rao, Suresh Kumar Gulla, et al.
Biochimica Et Biophysica Acta|May 16, 2016
Epidermal growth factor receptor inhibitor cancer drug gefitinib modulates cell growth and differentiation of acute myeloid leukemia cells via histamine receptorsManisha Yadav, Abhishek Kumar Singh, Harish Kumar, et al.
Cancer Letters|October 21, 2023
Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitisRam Vinod Roy, Nicolas Means, Geeta Rao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 8, 2020
KRCC1: A potential therapeutic target in ovarian cancerShailendra Kumar Dhar Dwivedi, Khader Shameer, Anindya Dey, et al.
Lancet (London, England)|July 19, 2021
COVID-19: the turning point for gender equalitySenait Fisseha, Gita Sen, Tedros Adhanom Ghebreyesus, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|December 25, 2025
Cystathionine Beta-Synthase Promotes Anoikis Resistance and Transcoelomic Metastasis in Ovarian Cancer via the SP1-ITGB1 axisPallab Shaw, Arpan Dey Bhowmik, Akrit Pran Jaswal, et al.
Lancet (London, England)|June 4, 2019
Why now for a Series on gender equality, norms, and health?Gary L Darmstadt, Lori Heise, Geeta Rao Gupta, et al.
EMBO Reports|August 28, 2020
MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancerGeeta Rao, Shailendra Kumar Dhar Dwivedi, Yushan Zhang, et al.
Materials Today (Kidlington, England)|October 3, 2022
Disabling partners in crime: Gold nanoparticles disrupt multicellular communications within the tumor microenvironment to inhibit ovarian tumor aggressivenessYushan Zhang, Chandra Kumar Elechalawar, Wen Yang, et al.
ACS Nano|May 2, 2023
Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS ActivationChandra Kumar Elechalawar, Geeta Rao, Suresh Kumar Gulla, et al.
ACS Nano|March 11, 2024
Correction to "Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation"Chandra Kumar Elechalawar, Geeta Rao, Suresh Kumar Gulla, et al.
Biochimica Et Biophysica Acta|May 16, 2016
Epidermal growth factor receptor inhibitor cancer drug gefitinib modulates cell growth and differentiation of acute myeloid leukemia cells via histamine receptorsManisha Yadav, Abhishek Kumar Singh, Harish Kumar, et al.
Cancer Letters|October 21, 2023
Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitisRam Vinod Roy, Nicolas Means, Geeta Rao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 8, 2020
KRCC1: A potential therapeutic target in ovarian cancerShailendra Kumar Dhar Dwivedi, Khader Shameer, Anindya Dey, et al.
Lancet (London, England)|July 19, 2021
COVID-19: the turning point for gender equalitySenait Fisseha, Gita Sen, Tedros Adhanom Ghebreyesus, et al.
Pageof 7